Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Genes & Development|June 8, 2001
In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effectsS Filleur, O V Volpert, A Degeorges, et al.International Journal of Cancer|March 28, 1997
Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-cultureX Dong-Le Bourhis, Y Berthois, G Millot, et al.International Journal of Cancer|October 9, 1996
Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6A Degeorges, R Tatoud, F Fauvel-Lafeve, et al.Molecular and Cellular Endocrinology|September 22, 1995
Somatostatin receptors in prostate tissues and derived cell cultures, and the in vitro growth inhibitory effect of BIM-23014 analogR Tatoud, A Degeorges, G Prévost, et al.Oncogene|May 26, 1999
The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-JunV Dejong, A Degeorges, S Filleur, et al.Breast Cancer Research and Treatment|March 11, 1998
Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?A Degeorges, A de Roquancourt, J M Extra, et al.The Prostate|July 6, 2000
LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasisG N Thalmann, R A Sikes, T T Wu, et al.Annales De Radiologie|January 1, 1989
[MRI study of parathyroid adenoma. Value of T2-weighted sequences]J M Brulé, A Degeorges, Y Mauss, et al.Epidemiology and Infection|March 15, 2019
Measles and rubella seroprevalence in a population of young adult blood donors, France 2013D Antona, P Morel, C Jacquot, et al.The Prostate|October 12, 1999
Loss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancerE R Hyytinen, H F Frierson, T W Sipe, et al.Pageof 3